LifeStance Health Group, Inc. (NASDAQ:LFST) Stock Has Consensus Target Price of $12.88 According to Brokerages

LifeStance Health Group, Inc. (NASDAQ:LFST) has received a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $13.12.

A number of equities analysts have weighed in on the company. Barclays upped their target price on LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a research note on Thursday, September 10th. Wall Street Zen downgraded LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 5th. Zacks Research lowered LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. KeyCorp boosted their price objective on LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a report on Monday. Finally, JPMorgan Chase & Co. upped their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th.

LifeStance Health Group Stock Down 0.1%

LFST opened at $12.11 on Monday. The company has a fifty day moving average price of $12.14 and a 200-day moving average price of $9.70. The firm has a market capitalization of $4.63 billion, a P/E ratio of 93.16 and a beta of 1.24. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. LifeStance Health Group has a one year low of $4.77 and a one year high of $13.56.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. The firm had revenue of $435.35 million for the quarter, compared to analysts’ expectations of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The business’s quarterly revenue was up 26.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.01) earnings per share. Equities research analysts expect that LifeStance Health Group will post 0.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.62, for a total transaction of $144,890,858.34. Following the sale, the insider owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. This trade represents a 12.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Lisa K. Miller sold 47,912 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $519,845.20. Following the sale, the chief operating officer directly owned 281,289 shares of the company’s stock, valued at $3,051,985.65. This represents a 14.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,777,580 shares of company stock valued at $146,433,781 in the last quarter. Corporate insiders own 3.50% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. WINTON GROUP Ltd increased its stake in LifeStance Health Group by 522.3% in the second quarter. WINTON GROUP Ltd now owns 186,589 shares of the company’s stock valued at $1,998,000 after acquiring an additional 156,607 shares during the last quarter. Engineers Gate Manager LP bought a new stake in LifeStance Health Group during the second quarter worth about $166,000. Integrated Wealth Concepts LLC bought a new stake in LifeStance Health Group during the second quarter worth about $91,000. IFP Advisors Inc lifted its stake in LifeStance Health Group by 316.5% during the second quarter. IFP Advisors Inc now owns 3,694 shares of the company’s stock worth $40,000 after purchasing an additional 2,807 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new position in shares of LifeStance Health Group in the 2nd quarter worth about $1,283,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc is a U.S.-based healthcare company that provides outpatient mental health services through a network of clinicians. Its services are delivered through both in-person appointments and a virtual care platform, allowing patients to access care in a range of settings.

The company offers psychiatric evaluation and treatment, psychotherapy, medication management, psychological and neuropsychological testing, and related behavioral health services. LifeStance serves children, adolescents, and adults, addressing conditions such as anxiety, depression, attention-deficit/hyperactivity disorder, and other mental health and behavioral concerns.

LifeStance operates across multiple states in the United States and combines company-operated clinics with telehealth services.